アブストラクト | Sevoflurane is a volatile anesthetic that can tolerate inhalation induction and is widely used for inducing anesthesia due to its pleasant odor. As a drug that has been on the market for nearly 30 years, the vast majority of adverse reactions have been documented. This study aims to improve the adverse reactions related to Sevoflurane through the mining, organizing and analysis of Food and Drug Administration Adverse Event Reporting System database data. We collected, organized, and analyzed reports from the first quarter of 2004 to the fourth quarter of 2022. We performed disproportionality analysis algorithms, including reporting odds ratio, the proportional reporting ratio values, to quantify the signal values of different adverse events (AEs). A total of 1126 AEs and 27 system organ classes were identified by performing statistics analysis system software. By combining algorithm calculations, we create a forest map of the top 30 AEs of the reporting odds ratio signal. Based on the reviewing relevant literature, we found that the vast majority of AEs have been reported in relevant studies. However, there is currently no study revealing the correlation between atrial fibrillation and Sevoflurane, which means that atrial fibrillation may be an unreported AE of Sevoflurane. In the present study, we found that atrial fibrillation may be a new adverse reaction of Sevoflurane through the Food and Drug Administration Adverse Event Reporting System database, which can function as a novel guideline to guide us in the more standardized use of Sevoflurane in clinical practice. |
ジャーナル名 | Medicine |
Pubmed追加日 | 2024/9/1 |
投稿者 | Yang, Xinxia; Shen, Yiming MD; Chen, Hang MD; Chen, Dongdong |
組織名 | Department of Anesthesiology, The Affiliated Lihuili Hospital, Ningbo University,;Ningbo, Zhejiang Province, P. R. China.;Department of Otology and Skull Base Surgery, National Health Commission Key;Laboratory of Hearing Medicine (Fudan University), Shanghai, P. R. China.;Department of Thoracic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo,;Zhejiang Province, P. R. China. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39213209/ |